|
|
|
|
|
by filoleg
2379 days ago
|
|
Who do you think does most of the pharmaceutical research? According to some quickly googleable info, private funding for pharmaceuticals is about 5 times that of public NIH research [0]. And before we assume that it all goes into the executive pay, turns out that private pharma in the US reinvests more of its revenues back into research and development than any other industry in the US (according to the same source). 0. https://www.drugcostfacts.org/public-vs-private-drug-funding |
|
But why talk about executive pay and not marketing? Research clearly takes a backseat to marketing at these shops:
https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-p...
As for who pays for research, you're right that pharma companies now pay for over half of US biomed research, something that's been true for about a decade. I don't know how that "5 times" figure was calculated, but my figures show the government currently finances about 1/3 of biomed research, including almost all basic research.
Of course, pharma benefits from that research, too, and looking only at spends understates the value of those contributions. One recent study found that
"NIH funding contributed to published research associated with every one of the 210 new drugs approved by the Food and Drug Administration from 2010–2016."
https://www.pnas.org/content/115/10/2329